🔗 Share this article

An underground economy for unapproved weight-loss medications is being driven by social media fitness personalities and sellers on communication apps, based on recent findings.

Experimental Drug Gaining Popularity Via Social Media

The experimental drug, which is still in research studies, is being advertised by online personalities for its alleged weight-reducing effects. Viewers are encouraged to contact these accounts privately for supplier links, while also obtaining promotional offers.

Active Commerce on Messaging Platforms

Additionally, a flourishing market exists on Telegram, where groups with thousands of members share “before and after” images, injection guides and assertions of rapid UK delivery. Sellers market the drug there before redirecting buyers to other platforms for purchases.

Learning About Retatrutide

Retatrutide is an investigational injectable created by American pharmaceutical company Eli Lilly. The drug targets three gut hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Preliminary studies indicate it could assist individuals reduce up to a quarter of their body weight. Referred to as the “triple G”, the substance is being hailed online as the next Ozempic.

Healthcare Experts Express Concerns

Nevertheless, doctors and pharmacists have warned that the sale of what remains an unapproved medication in the United Kingdom is a cause for concern and could lead to individuals administering products of unknown origin.

Some experts said the demand for retatrutide could be linked to the rising price of licensed slimming products such as Mounjaro.

Regulatory Position and Implementation

Marketing retatrutide on TikTok or Telegram is prohibited in the United Kingdom, as it is an unlicensed drug that must not be promoted or distributed for personal consumption under the Human Medicines Regulations 2012.

Some content creators try to circumvent the rules by calling to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted drug, but advertising and supply can still breach medicines, marketing, and consumer laws, potentially leading to penalties, prosecution or prison.

Service Response and Material Removal

According to the social media company, the platform has taken down violative content and prohibited related hashtags and search suggestions. The organization stated it was committed to maintaining the service safe and investing in strengthening compliance measures.

Online Marketplace Operations

Investigations also found communities with up to nine thousand members marketing retatrutide using Telegram's built-in discovery tool, which operates like a public directory. Typing “retatrutide” instantly brings up channels with thousands of members, populated with photos of slimming results, positive testimonials and step-by-step instructions for preparing or administering at home.

Within moments of entering one group, a seller shared WhatsApp details, where most transactions take place. The seller sent an instruction manual and guaranteed delivery within two days. When asked whether the substance was genuine, one seller said: “You can’t be sure.” Another provided a photo of a alleged testing documentation. Not one inquired about body mass, medical conditions or previous experience.

Item Details and Pricing

Within these groups, messages show black plastic parcels with Royal Mail labels, claiming to contain new batches. One message read: “It took eight of us to load them this morning.”

Customers can select between dry substance containers, mixed at residence with sterile water, or ready-to-use pens usually priced at 160 pounds for 20mg. When questioned how much time a injector should be used, sellers give contradictory responses ranging from a several days to “depends on your body”.

Platform Moderation and Security Actions

A spokesperson for the messaging service said it actively moderated harmful content on its service including material that encouraged the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.

Medical Expert Cautions

“People are administering substances they can’t verify. Even if the science behind this drug is sound, these digital products may not contain what they advertise,” stated Jason Murphy, the head of pharmacy at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor connected the increase in demand to recent price rises for approved slimming drugs such as Mounjaro. “With prices increasing, patients are using social media. But fake injections are extremely dangerous. You can’t be certain what’s contained or whether the environment they were made in was clean,” she said.

Her staff has already encountered patients harmed by personal administration from unconfirmed suppliers. “We recognize the disappointment, but buying from Telegram or WhatsApp is gambling with your health,” stated the doctor. “These substances could be impure or incorrectly dosed.”

Manufacturer Position

A representative from Eli Lilly stated retatrutide was in third stage clinical trials and had not been reviewed or authorized by any government authority globally. “Therefore at this point no one can market [it] for personal consumption,” they explained, adding that any product “misleadingly claiming itself as a company investigational substance not yet approved … may subject patients to potentially serious health risks”.